Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma

30 Mar 2022

Abstract excerpt

Long-term survivals of patients with hepatocellular carcinoma (HCC) remain unfavorable, which is largely attributed to active carcinogenesis. Growing studies have suggested that the reliable gene signature could act as an independent prognosis factor for HCC patients. We tried to screen the survival-related genes and develop a prognostic prediction model for HCC patients based on the expression profiles of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Cancer Mechanisms and Therapy
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35402624
DOI: 10.1155/2022/9117205

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular CarcinomaPMID 35402624Read ↗

Development and validation of a novel immune-related prognostic model in hepatocellular carcinomaSemantic proximity Read ↗

Identification and validation of an immune-related prognostic signature for hepatocellular carcinomaSemantic proximity Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.Semantic proximity Read ↗

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltrationSemantic proximity Read ↗

Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular CarcinomaSemantic proximity Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinomaSemantic proximity Read ↗

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signatureSemantic proximity Read ↗

Integrative study reveals the prognostic and immunotherapeutic value of CTCs/CTMs -related prognostic signature in Hepatocellular carcinomaSemantic proximity Read ↗

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity Read ↗

An immunogenic cell death-associated gene signature predicts prognosis in hepatocellular carcinomaSemantic proximity Read ↗

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma PrognosisSemantic proximity Read ↗

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.